ASC-话题@MedSci

#ASC#

1352篇内容 | 3354人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939390, encodeId=ddbd1939390ad, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？, objectType=article, longId=728465, objectId=896be284651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896be284651f, replyNumber=0, likeNumber=46, createdTime=2023-01-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896be284651f, moduleTitle=ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896be284651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939416, encodeId=44f119394165f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 肺癌放疗后并发房颤的风险因素研究, objectType=article, longId=728660, objectId=5265e286608e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5265e286608e, replyNumber=0, likeNumber=33, createdTime=2023-05-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5265e286608e, moduleTitle=ASCO 2022 | 肺癌放疗后并发房颤的风险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5265e286608e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939367, encodeId=2566193936e2e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：RP1+nivo治疗皮肤癌的疗效与安全性——IGNYTE研究的最新结果, objectType=article, longId=728230, objectId=1cdae2823048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cdae2823048, replyNumber=0, likeNumber=62, createdTime=2023-02-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cdae2823048, moduleTitle=2022 ASCO：RP1+nivo治疗皮肤癌的疗效与安全性——IGNYTE研究的最新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cdae2823048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939464, encodeId=5bb51939464b1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响, objectType=article, longId=733951, objectId=2a74e33951db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a74e33951db, replyNumber=0, likeNumber=24, createdTime=2023-03-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a74e33951db, moduleTitle=Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a74e33951db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939334, encodeId=6c99193933443, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：SGLT2抑制剂可降低糖尿病肾病患者的多种不良临床结局风险！, objectType=article, longId=301816, objectId=ce7530181602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce7530181602, replyNumber=0, likeNumber=47, createdTime=2022-11-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce7530181602, moduleTitle=Cardiovasc Diabetol：SGLT2抑制剂可降低糖尿病肾病患者的多种不良临床结局风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce7530181602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939354, encodeId=ec4b1939354e1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：白脂素诱导糖尿病下肢外周动脉疾病血管内皮细胞向间质细胞转化, objectType=article, longId=727593, objectId=c7c6e27593e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7c6e27593e3, replyNumber=0, likeNumber=56, createdTime=2023-02-01, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7c6e27593e3, moduleTitle=Cardiovasc Diabetol：白脂素诱导糖尿病下肢外周动脉疾病血管内皮细胞向间质细胞转化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7c6e27593e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939415, encodeId=3b0b1939415a3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=聚焦 2022 ASCO 肺癌研究，重磅发现荟萃, objectType=article, longId=728631, objectId=8495e2863194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8495e2863194, replyNumber=0, likeNumber=36, createdTime=2022-12-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8495e2863194, moduleTitle=聚焦 2022 ASCO 肺癌研究，重磅发现荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8495e2863194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939431, encodeId=07101939431fb, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化, objectType=article, longId=728696, objectId=e3ebe28696d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3ebe28696d8, replyNumber=0, likeNumber=78, createdTime=2022-06-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3ebe28696d8, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3ebe28696d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939341, encodeId=7ef41939341cc, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关, objectType=article, longId=724356, objectId=3192e24356b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3192e24356b3, replyNumber=0, likeNumber=34, createdTime=2022-06-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3192e24356b3, moduleTitle=Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3192e24356b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939319, encodeId=786b1939319ea, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：血Asprosin可作为糖尿病患者外周动脉疾病的诊断标志物, objectType=article, longId=299525, objectId=66af299525bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66af299525bf, replyNumber=0, likeNumber=39, createdTime=2022-10-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66af299525bf, moduleTitle=Cardiovasc Diabetol：血Asprosin可作为糖尿病患者外周动脉疾病的诊断标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66af299525bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939438, encodeId=7a07193943811, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度情况及其对心血管事件的预测价值, objectType=article, longId=729226, objectId=6960e292261e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6960e292261e, replyNumber=0, likeNumber=39, createdTime=2022-12-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6960e292261e, moduleTitle=Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度情况及其对心血管事件的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6960e292261e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939467, encodeId=8462193946e08, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Rheumatology：血小板抑制剂在系统性硬化相关指端溃疡中的应用，DU-VASC模型推导和验证, objectType=article, longId=734091, objectId=3bede34091e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bede34091e4, replyNumber=0, likeNumber=32, createdTime=2022-12-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bede34091e4, moduleTitle=Rheumatology：血小板抑制剂在系统性硬化相关指端溃疡中的应用，DU-VASC模型推导和验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bede34091e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939350, encodeId=acea1939350a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, objectType=article, longId=726070, objectId=b59ee2607052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59ee2607052, replyNumber=0, likeNumber=39, createdTime=2022-11-17, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59ee2607052, moduleTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59ee2607052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939474, encodeId=11bf19394e466, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性, objectType=article, longId=735302, objectId=896ce35302c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896ce35302c5, replyNumber=0, likeNumber=55, createdTime=2023-01-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896ce35302c5, moduleTitle=Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896ce35302c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939372, encodeId=932219393e278, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, objectType=article, longId=728258, objectId=3b8ae28258e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b8ae28258e7, replyNumber=0, likeNumber=41, createdTime=2022-07-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b8ae28258e7, moduleTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b8ae28258e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939332, encodeId=69e71939332d3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：甘油三酯葡萄糖指数越高，颈动脉粥样硬化的可能性越大！, objectType=article, longId=301183, objectId=af9030118309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9030118309, replyNumber=0, likeNumber=44, createdTime=2022-08-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9030118309, moduleTitle=Cardiovasc Diabetol：甘油三酯葡萄糖指数越高，颈动脉粥样硬化的可能性越大！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9030118309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939355, encodeId=289e1939355e7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多, objectType=article, longId=727474, objectId=e33be2747453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e33be2747453, replyNumber=0, likeNumber=60, createdTime=2022-12-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e33be2747453, moduleTitle=Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e33be2747453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939358, encodeId=e6a71939358fb, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO速递：第一波剧透来了 ——非小细胞转移性专场, objectType=article, longId=727883, objectId=f1dce27883fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1dce27883fb, replyNumber=0, likeNumber=40, createdTime=2023-02-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1dce27883fb, moduleTitle=ASCO速递：第一波剧透来了 ——非小细胞转移性专场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1dce27883fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939371, encodeId=f5fa19393e14b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏, objectType=article, longId=728328, objectId=9b53e28328a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b53e28328a2, replyNumber=0, likeNumber=11, createdTime=2022-10-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b53e28328a2, moduleTitle=【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b53e28328a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939425, encodeId=5acc1939425cf, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！, objectType=article, longId=728766, objectId=ebf0e2876637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebf0e2876637, replyNumber=0, likeNumber=46, createdTime=2023-04-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebf0e2876637, moduleTitle=ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebf0e2876637)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？

2023-01-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 肺癌放疗后并发房颤的风险因素研究

2023-05-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：RP1+nivo治疗皮肤癌的疗效与安全性——IGNYTE研究的最新结果

2023-02-13

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响

2023-03-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：SGLT2抑制剂可降低糖尿病肾病患者的多种不良临床结局风险！

2022-11-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：白脂素诱导糖尿病下肢外周动脉疾病血管内皮细胞向间质细胞转化

2023-02-01

quxin068 (审核中...)

前往app查看评论内容

#ASC#

聚焦 2022 ASCO 肺癌研究，重磅发现荟萃

2022-12-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化

2022-06-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关

2022-06-04

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：血Asprosin可作为糖尿病患者外周动脉疾病的诊断标志物

2022-10-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度情况及其对心血管事件的预测价值

2022-12-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Rheumatology：血小板抑制剂在系统性硬化相关指端溃疡中的应用，DU-VASC模型推导和验证

2022-12-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制

2022-11-17

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性

2023-01-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究

2022-07-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：甘油三酯葡萄糖指数越高，颈动脉粥样硬化的可能性越大！

2022-08-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：糖尿病患者体重减轻超过10%，死亡风险将增加两倍多

2022-12-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO速递：第一波剧透来了 ——非小细胞转移性专场

2023-02-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏

2022-10-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！

2023-04-02

科室
- - 订阅+
  - 更多科室
工具
服务